Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/35697
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorPinillos Madrid, Juan Fernando-
dc.contributor.authorRojas Vargas, Laura Daniela-
dc.contributor.authorGallardo Cabrera, Cecilia-
dc.date.accessioned2023-06-28T19:35:23Z-
dc.date.available2023-06-28T19:35:23Z-
dc.date.issued2016-
dc.identifier.citationPinillos JF, Rojas L, Gallardo C. ADSORPTION OF ERLOTINIB TO MULTIWALLED CARBON NANOTUBES. Int J Pharm Pharm Sci [Internet]. 2016 Jan. 1 [cited 2023 Jun. 29];8(1):399-403. Available from: https://journals.innovareacademics.in/index.php/ijpps/article/view/9580spa
dc.identifier.issn0975-1491-
dc.identifier.urihttps://hdl.handle.net/10495/35697-
dc.description.abstractABSTRACT: Objective: The objective of this research was to assess for the first time the adsorption of erlotinib (ERL) in three types of multi walled carbon nanotubes, as feasible alternative method to removal antineoplastic from wastewater. Methods: Both multi walled carbon nanotubes without modification (pristine-CNT) and modified carbon nanotubes by oxidation (CNT-COOH) and amination (CNT-NH2 Results: The characterization showed that the surface of pristine-CNT was modified. Different sedimentation behavior was observed in the three types of CNTs. ERL adsorption followed the Langmuir model for CNT-NH) were used as adsorbents. They were characterized by Transmission electron microscopy, Raman spectroscopy, FT-IR spectroscopy, and Thermogravimetric analysis. In addition, the stability of CNTs suspensions were monitored. The ERL residual concentration in the equilibrium, from the bath adsorption, experiments was quantified by HPLC. The experiment data were fitted to Langmuir and Freundlich models. Conclusion: It was found that CNTs have a high capacity of adsorption of ERL, indicating the potential of CNTs to removal this antineoplastic drug from hospital wastewater.spa
dc.format.extent5spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherIJPPSspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleAdsorption of Erlotinib to Multiwalled Carbon Nanotubesspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Estabilidad de Medicamentos, Cosméticos y Alimentos (GEMCA)spa
oaire.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2656-0097-
oaire.citationtitleInternational Journal of Pharmacy and Pharmaceutical Sciencesspa
oaire.citationstartpage399spa
oaire.citationendpage403spa
oaire.citationvolume8spa
oaire.citationissue1spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameDepartamento Administrativo de Ciencia, Tecnología e Innovación, COLCIENCIASspa
dc.publisher.placeBhopal, Indiaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAntineoplásicos-
dc.subject.decsAntineoplastic Agents-
dc.subject.decsClorhidrato de Erlotinib-
dc.subject.decsErlotinib Hydrochloride-
dc.subject.decsNanotubos de Carbono-
dc.subject.decsNanotubes, Carbon-
dc.subject.decsAguas Residuales-
dc.subject.agrovocWastewater-
dc.identifier.urlhttps://journals.innovareacademics.in/index.php/ijpps/article/view/9580spa
dc.description.researchgroupidCOL0035117spa
dc.relation.ispartofjournalabbrevInt. J. Pharm. Pharm. Sci.spa
oaire.funderidentifier.rorRoR:048jthh02-
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
PinillosJuan_2016_AdsorptionErlotinib.pdfArtículo de investigación790.62 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons